脂毒性作为肥胖和糖尿病心肌病的治疗点
1Department of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, United States.
概括
过度的脂肪积累和不良的生活方式促进肥胖和脂毒性,损害细胞和器官. 本综述探讨了脂毒性机制及其与糖尿病心肌病症等心脏代谢性疾病的联系.
科学领域:
- 代谢研究的研究.
- 细胞生物学 细胞生物学
- 心血管科学 心血管科学
背景情况:
- 肥胖与不健康的饮食和久坐不动的生活方式有关.
- 过度的脂质积累会导致脂质毒性,破坏细胞功能.
- 脂质毒性导致细胞内网膜应激,线粒体功能障碍和炎症.
研究的目的:
- 审查最近在理解脂毒性机制方面的进展.
- 讨论脂质毒性在肥胖和心脏代谢疾病中的作用.
- 专注于脂毒性和糖尿病性心肌病.
主要方法:
- 评论最近的文献关于OMIC技术和分析方法.
- 对临床研究结果的分析.
- 对表观遗传学,表观转录学和脂质滴状功能障碍知识的综合.
主要成果:
- 脂毒性机制包括肠道失调,表观遗传变化和脂滴功能障碍.
- 变化的膜脂质组成和翻译后的修改有助于脂毒性.
- 脂毒性是发展肥胖相关心脏代谢疾病的关键因素.
结论:
- 了解脂毒性机制对于解决肥胖和相关疾病至关重要.
- 脂毒性心肌病变是代谢障碍的一个重要问题.
- 对脂毒性途径的进一步研究可以为治疗策略提供信息.
相关概念视频
Overview of Lipid Metabolism
1.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.4K
Obesity
468
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
468
Glucagon-like Receptor Agonists
318
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
318
Heart Failure Drugs: Inotropic Agents
573
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
573
Carbohydrate Metabolism
11.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.0K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
652
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
652


